Ms. Liu has over a decade of experience in semiconductor-based biochip diagnostics, specializing in chemical surface modification and detection platform development. As Molsentech’s Regional R&D Lead, she oversees cross-disciplinary programs in wafer inspection, process optimization, and technology integration—driving key innovations that define the company’s biochip diagnostic platform.

In 2018, she led the development of Molsentech’s first automated micro-molecular measurement prototype. The following year, she earned the Bronze Award at The Deep Tech Challenge co-hosted by Applied Materials and ITRI, and represented the company at MEDICA 2019 in Germany. 

In 2021, she spearheaded the development and clinical validation of Molsentech’s COVID-19 diagnostic product, which obtained tFDA EUA approval—a pivotal milestone in the company’s path toward commercialization.

Through her leadership, Ms. Liu has been instrumental in advancing Molsentech’s core technologies and establishing a robust R&D foundation that continues to propel the company’s innovation pipeline.